Independent Bank Corporation reported strong second quarter 2026 financial results, with net income of $18.8 million, or $0.90 per diluted share, compared to $16.9 million, or $0.81 per diluted share, in the prior-year period. Key highlights include a net interest margin of 3.71%, a 2.2% increase in net interest income...

Intel Corporation reported its second-quarter 2026 financial results, with revenue reaching $16.1 billion, a 25% increase year-over-year. The company reported a GAAP net loss of $11.0 billion, or $(2.16) per share, and a non-GAAP net income of $2.2 billion, or $0.42 per share. For the third quarter of 2026, Intel forec...

Intelligent Bio Solutions Inc. announced on July 23, 2026, that it has resolved all cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This milestone follows the completion of independent third-party penetration testing, which identified no major vulnerabilities. The company remedia...

Isabella Bank Corporation reported net income of $5.0 million, or $0.69 per diluted share, for the second quarter of 2026, a slight increase from $5.0 million, or $0.68 per diluted share, in the second quarter of 2025. The company experienced loan growth of $30.7 million and an improvement in net interest margin (NIM) ...

On July 20, 2026, ImageneBio, Inc. appointed Yanina Grant-Huerta as Chief Financial Officer, principal financial officer, and principal accounting officer. Ms. Grant-Huerta, age 49, previously served as Chief Accounting Officer at Atara Biotherapeutics and spent 14 years at Amgen in various financial roles. She succeed...

Incannex Healthcare Inc. has announced the commencement of participant screening for its DReAMzz Phase 2 study evaluating IHL-42X for the treatment of obstructive sleep apnea (OSA). The study aims to optimize the dosing profile of IHL-42X and gather further data on the relationship between objective sleep metrics and p...

On July 23, 2026, Inhibikase Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, IKT-001, for the treatment of Pulmonary Arterial Hypertension (PAH). IKT-001 is a prodrug of imatinib mesylate designed to improve pulmonary vascu...

InspireMD, Inc. received a notice from Nasdaq on July 17, 2026, stating that the company is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's common stock closing bid price was below $1.00 for 30 consecutive business days from June 3, 2026, to Jul...

Intellicheck, Inc. has adopted Second Amended and Restated Bylaws, effective immediately as of July 17, 2026. These updated bylaws modernize the company's governance in line with Delaware law. Key changes include provisions for electronic transmission of notices and meetings, allowing remote participation, and electron...

JPMorgan Chase & Co. filed a Form 8-K on July 21, 2026, reporting an amendment to Section 2.03 of its By-laws. Effective July 21, 2026, the amendment stipulates that the Lead Independent Director, if one is appointed, shall be chosen by the non-management directors. The filing also lists various classes of preferred st...

On July 23, 2026, JPMorgan Chase & Co. completed public offerings totaling $9 billion in debt securities. The offerings included: $500 million Floating Rate Notes due 2030, $2.5 billion Fixed-to-Floating Rate Notes due 2030, $3 billion Fixed-to-Floating Rate Notes due 2032 (collectively $6 billion Senior Notes), and $3...

James Hardie Industries plc announced preliminary financial results for the fiscal first quarter ended June 30, 2026, exceeding prior guidance. The company's performance was driven by strong sales in Siding & Trim, with better-than-expected sell-through and underlying demand. The Deck, Rail & Accessories segment also s...

On July 22, 2026, KALA BIO, Inc. filed a prospectus supplement under Rule 424(b) in connection with an 'at-the-market' (ATM) equity offering. The company may issue and sell shares of its common stock having an aggregate offering price of up to $250,000,000. These sales are conducted pursuant to an At The Market Offerin...

Kingstone Companies, Inc. announced that its Board of Directors has approved a 20% increase in the Company's quarterly cash dividend to $0.06 per share from $0.05 per share. This decision reflects confidence in the company's earnings power and positive outlook for profitable growth. The dividend is payable on August 26...

Kearny Financial Corp. reported its fourth quarter and fiscal year 2026 financial results, announcing net income of $7.2 million ($0.11 per diluted share) for Q4 and $36.3 million ($0.57 per diluted share) for the full fiscal year, representing a 39% year-over-year increase. The company declared a quarterly cash divide...

Kinsale Capital Group reported strong second quarter 2026 financial results with net income of $175.9 million ($7.72 per diluted share), a 34% increase from $134.1 million ($5.76 per share) in Q2 2025. For the first half of 2026, net income was $288.4 million ($12.58 per share) compared to $223.3 million ($9.59 per sha...

Knowles Corporation reported its financial results for the second quarter ended June 30, 2026. The company announced revenues of $167 million, a 14% increase year over year. Diluted EPS from continuing operations increased to $0.21, and non-GAAP diluted EPS from continuing operations rose to $0.33. Net cash from operat...

Landstar System, Inc. has announced key executive leadership changes. William Clement has been appointed as the new Chief Commercial Officer, effective August 1, 2026. He will be responsible for leading the company's commercial strategy, supporting the independent agent network, and enhancing customer relationships. Cl...

LightPath Technologies, Inc. has entered into an equity transfer agreement to sell 100% of its interest in LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. to Hengtu Optical Technology Co., Ltd. for $4,500,000. The payment is to be made within five years, with annual minimum payments and a 4% financing interest....

This filing is a Current Report on Form 8-K for LivePerson, Inc., dated July 23, 2026. It primarily concerns the pending merger transaction between LivePerson and SoundHound AI, Inc. The report includes a press release highlighting the benefits of the merger for LivePerson stockholders, a microsite webpage with informa...

Lockheed Martin Corporation reported strong financial results for the second quarter of 2026. Sales increased by 11% to $20.1 billion, driven by growth across all segments, particularly in integrated air and missile defense programs and F-35 production. Net earnings were $1.8 billion, or $7.94 per share, a significant ...

Luxfer Holdings PLC (NYSE: LXFR) announced the details for its second quarter 2026 earnings conference call, scheduled for Wednesday, July 29, 2026, at 8:30 a.m. Eastern Time. The call will feature participation from CEO Andy Butcher, CFO Steve Webster, and VP of Investor Relations Kevin Grant. Dial-in registration is ...

Ladder Capital Corp reported its financial results for the quarter ended June 30, 2026. The company announced a GAAP income before taxes of $16.3 million, or $0.12 of diluted earnings per share (EPS), and distributable earnings of $30.8 million, or $0.24 of distributable EPS. The CEO, Brian Harris, highlighted a strong...

Lazard, Inc. reported financial results for its second quarter and first half of 2026. For the second quarter, net revenue was $808 million and adjusted net revenue was $786 million. For the first half, net revenue was $1,564 million and adjusted net revenue was $1,459 million. On a U.S. GAAP basis, second-quarter net ...

Liberty Energy Inc. reported its second quarter 2026 financial and operational results, with revenue reaching $1.2 billion, a 14% increase year-over-year. The company posted a net income of $43 million, or $0.26 per diluted share, and Adjusted EBITDA of $151 million. Key developments during the quarter included a joint...